Tag: ImmunoGen

Bayer antibody-drug conjulate (ADC) misses in phase 2 mesothelioma trial

Bayer's antibody-drug conjulate (ADC) anetumab ravtansine has failed to show improvements in the survival rates of mesothelioma patients. Stock prices of Bayer's collaborators ImmunoGen...

Popular

More Delays Reported for Levante Dam Upgrade

Sueña Torrevieja alert that the works on the Levante...

Alicante Car and Motorcycle Fair at IFA_FIRA

IFA-FIRA Alacant hosts the largest selection of vehicles...

Exclusive flamenco premiere in San Javier by Josué Vivancos, Elijo Vivir

Josué Vivancos will debut in his first solo...

Trial reopened for the Torrevieja parade of children in lingerie

A court in Torrevieja has agreed to reopen the...